Inovio Pharma jumps on MERS vaccine news

|About: Inovio Pharmaceuticals, Inc. (INO)|By:, SA News Editor

Inovio Pharmaceuticals (INO) says preclinical testing of a MERS vaccine "induced robust and durable immune responses."

More specifically, "vaccine constructs were observed to induce strong neutralizing antibodies and broad CD8+ T cells in mice."

Although less contagious, the fatality rate for MERS is around five times that for SARS. (PR)

INO +16% premarket

Subscribe for full text news in your inbox